Results 11 to 20 of about 131,813 (277)

Health disparities in chronic liver disease

Hepatology, EarlyView., 2022
Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian, Marina Serper, Norah Terrault, Lauren D. Nephew   +3 more
wiley   +1 more source

Identification of novel neutralizing determinants for protection against HCV

Hepatology, EarlyView., 2022
Identification of novel neutralizing determinants for protection against hepatitis C virus. Abstract Background and Aims HCV evasion of neutralizing antibodies (nAb) results in viral persistence and poses challenges to the development of an urgently needed vaccine.
Garazi P. Alzua, Anne F. Pihl, Anna Offersgaard, Rodrigo Velázquez‐Moctezuma, Carlos R. Duarte Hernandez, Elias H. Augestad, Ulrik Fahnøe, Christian K. Mathiesen, Henrik Krarup, Mansun Law, Jannick Prentoe, Jens Bukh, Judith M. Gottwein   +12 more
wiley   +1 more source

Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening

Hepatology Communications, EarlyView., 2022
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff, David Smookler, Mia J. Biondi, Scott Enman, Tintin Fuliang, Sana Mahmood, Agustina Crespi, Maria Marquez, Rafique Van Uum, Lucy You, Brett Wolfson‐Stofko, Renee Logan, Erin LeDrew, Hemant Shah, Harry Janssen, Camelia Capraru, Elisa Venier, Jordan J. Feld   +17 more
wiley   +1 more source

The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study

Frontiers in Cellular and Infection Microbiology, 2021
ObjectivesTo compare the safety, immunogenicity, and immune persistence of hepatitis A (HA) vaccines between HBs-Ag-positive and -negative participants.Method9000 participants were enrolled in the phase IV study of live attenuated HA (HA-L) or ...
Xiaodan Wang, Xiaodan Wang, Xiaodan Wang, Jia Luo, Jia Luo, Jia Luo, Fubao Ma, Guodong Kang, Zhengrong Ding, Yue Pan, Yue Pan, Yue Pan, Yujiao Zhao, Yujiao Zhao, Yujiao Zhao, Junying Chen, Junying Chen, Junying Chen, Kai Feng, Kai Feng, Kai Feng, Lingmei Yan, Lingmei Yan, Lingmei Yan, Juan Zhang, Juan Zhang, Juan Zhang, Juan Zhang, Linhao Li, Linhao Li, Linhao Li, Linhao Li, Qiangping Lan, Qiangping Lan, Qiangping Lan, Daiying Li, Daiying Li, Daiying Li, Xiaolei Yang, Xiaolei Yang, Xiaolei Yang, Guoliang Li, Guoliang Li, Guoliang Li, Jingsi Yang, Jingsi Yang, Jingsi Yang, Qiangming Sun, Qiangming Sun, Qiangming Sun   +49 more
doaj   +1 more source

Community perceptions of a malaria vaccine in the Kintampo districts of Ghana. [PDF]

, 2013
BACKGROUND: Malaria remains the leading cause of morbidity and mortality in sub-Saharan Africa despite tools currently available for its control. Making malaria vaccine available for routine use will be a major hallmark, but its acceptance by community ...
A Bingham, A Dodoo, A Launiala, A Olotu, AK Rowe, AS Jegede, C Wongsrichanalai, CA Baume, CA de Quadros, Dan-Bright S Dzorgbo, DB Dery, DI Ojakaa, E Klinkenberg, F Nuwaha, FN Binka, G GSS, Kojo A Senah, KP Asante, Kwaku P Asante, Lawrence G Febir, PW Chung, RW Snow, S Owusu-Agyei, S Owusu-Agyei, S Owusu-Agyei, Seth Owusu-Agyei, ST Agnandji, ST Agnandji, TE Nkya, Timothy S Letsa, WHO   +30 more
core   +2 more sources

Immune response to vaccines in children with celiac disease [PDF]

, 2017
Celiac disease (CD) is an immune-mediated systemic condition evoked by ingestion of gluten and related prolamines in genetically susceptible subjects. The disease is featured by a variable combination of clinical signs, specific antibodies, HLA-DQ2 and ...
ANANIA, Caterina, CHIESA, CLAUDIO, OLIVERO, FRANCESCA, PACIFICO, Lucia, Spagnolo, Alessandra   +4 more
core   +1 more source

METHODS FOR ASSESSMENT OF THE SPECIFIC ACTIVITY OF DRUGS FOR PREVENTION OF HEPATITIS B

Вопросы вирусологии, 2017
The immunologic activity (specific activity) is one of the main indicators of quality of vaccines for prophylaxis of hepatitis B, along with their safety.
E. L. Postnova, N. V. Shalunova, K. A. Sarkisyan, A. A. Movsesyants   +3 more
doaj   +1 more source

A Review of Racial and Ethnic Disparities in Immunizations for Elderly Adults

Journal of Primary Care & Community Health, 2021
Vaccine preventable diseases are responsible for a substantial degree of morbidity in the United States as over 18 million annual cases of vaccine preventable disease occur in the U.S. annually.
Oluchi Elekwachi, La’Marcus T. Wingate, Veronica Clarke Tasker, Lorraine Aboagye, Tadesse Dubale, Dagmawit Betru, Razan Algatan   +6 more
doaj   +1 more source

The reform of the Italian legislation on childhood immunization [PDF]

, 2018
Upon the proposal of the Italian government, Law n. 191/2017 has been enacted, meant to considerably raise the number of mandatory vaccinations, while leaving several others merely "recommended" (non-mandatory).
Cocchiara, Rosario Andrea, La Torre, Giuseppe, Marinelli, Enrico, Montanari Vergallo, Gianluca, Zaami, Simona   +4 more
core   +1 more source

Prevenção das hepatites virais através de imunização Viral hepatitis prevention by immunization

Jornal de Pediatria, 2006
OBJETIVO: Apresentar uma revisão atualizada e crítica da prevenção das hepatites virais A e B, através de imunização. FONTE DOS DADOS: Revisão de artigos médicos obtidos através do banco de dados MEDLINE, sendo selecionados os mais atuais e ...
Cristina Targa Ferreira, Themis Reverbel da Silveira   +1 more
doaj   +1 more source